CLINICAL_TRIALS
trial_result
· 2015-07-16
Clinical Trial Update: LycoRed 40051 Product as a Countermeasure to Exercise Stress [NA]
Summary
A completed clinical trial update evaluating LycoRed 40051 Product as a countermeasure to exercise-induced inflammation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Appalachian State University | Conditions: Inflammation | NA | Status: COMPLETED